Hemogenyx Pharmaceuticals Plc (HEMO.L)
GBp 320.0
(-8.57%)
GBp 320.0
(-8.57%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -5.73 Million GBP | -55.81% |
| 2022 | -3.42 Million GBP | -33.79% |
| 2021 | -2.38 Million GBP | -30.87% |
| 2020 | -1.95 Million GBP | -43.53% |
| 2019 | -1.36 Million GBP | 7.2% |
| 2018 | -1.63 Million GBP | -113.88% |
| 2017 | -837.06 Thousand GBP | -125.67% |
| 2016 | -447.15 Thousand GBP | -2659.6% |
| 2015 | -0.59 GBP | -75.74% |
| 2014 | -6270.00 GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1287.17 GBP | -82.74% |
| 2024 Q1 | -1287.17 GBP | 32.01% |
| 2023 Q4 | -613.35 GBP | 28.42% |
| 2023 FY | - GBP | -43.53% |
| 2023 Q2 | -3.89 Million GBP | -189665.46% |
| 2023 Q3 | -856.86 GBP | 99.98% |
| 2023 Q1 | -2053.22 GBP | 99.91% |
| 2022 Q2 | -1.11 Million GBP | -199900.0% |
| 2022 Q1 | -555.51 GBP | 99.96% |
| 2022 Q4 | -2.32 Million GBP | -164492.66% |
| 2022 FY | - GBP | -33.79% |
| 2022 Q3 | -1411.04 GBP | 99.87% |
| 2021 Q3 | -756.73 GBP | 99.93% |
| 2021 Q2 | -1.09 Million GBP | -199900.0% |
| 2021 Q1 | -549.66 GBP | 99.95% |
| 2021 Q4 | -1.47 Million GBP | -195094.34% |
| 2021 FY | - GBP | -30.87% |
| 2020 Q1 | -430.52 GBP | 99.95% |
| 2020 FY | - GBP | -43.53% |
| 2020 Q3 | -609.75 GBP | 99.93% |
| 2020 Q4 | -1.18 Million GBP | -193849.29% |
| 2020 Q2 | -861.03 Thousand GBP | -199899.54% |
| 2019 Q1 | -379.80 GBP | 16.96% |
| 2019 Q4 | -829.81 Thousand GBP | -191147.17% |
| 2019 FY | - GBP | 7.2% |
| 2019 Q2 | -759.6 Thousand GBP | -199900.53% |
| 2019 Q3 | -433.89 GBP | 99.94% |
| 2018 Q3 | -457.37 GBP | -27.85% |
| 2018 Q2 | -357.74 GBP | 0.0% |
| 2018 Q1 | -357.74 GBP | -16.11% |
| 2018 FY | - GBP | -113.88% |
| 2018 Q4 | -457.37 GBP | 0.0% |
| 2017 Q4 | -308.10 GBP | 0.0% |
| 2017 Q2 | -110.43 GBP | -0.0% |
| 2017 Q3 | -308.10 GBP | -179.01% |
| 2017 Q1 | -110.43 GBP | 0.0% |
| 2017 FY | - GBP | -125.67% |
| 2016 Q4 | - GBP | 0.0% |
| 2016 Q2 | - GBP | 0.0% |
| 2016 FY | - GBP | -2659.6% |
| 2015 FY | - GBP | -75.74% |
| 2014 FY | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|